Chemtura (CHMT) Misses Q4 EPS by 2c

Chemtura (NYSE: CHMT) reported Q4 EPS of $0.10, $0.02 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $467 million versus the consensus estimate of $484.8 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37